Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase
- PMID: 10542297
- DOI: 10.1074/jbc.274.45.32507
Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase
Abstract
TYK2, a Janus kinase, plays both structural and catalytic roles in type I interferon (IFN) signaling. We recently reported (Rani, M. R. S., Gauzzi, C., Pellegrini, S., Fish, E., Wei, T., and Ransohoff, R. M. (1999) J. Biol. Chem. 274, 1891-1897) that catalytically active TYK2 was necessary for IFN-beta to induce the beta-R1 gene. We now report IFN-beta-mediated activation of STATs and other components in U1 (TYK2-null) cell lines that were complemented with kinase-negative (U1.KR930) or wild-type TYK2 (U1.wt). We found that IFN-beta induced phosphorylation on tyrosine of STAT3 in U1.wt cells but not in U1.KR930 cells, whereas STAT1 and STAT2 were activated in both cell lines. Additionally, IFN-beta-mediated phosphorylation of interferon-alpha receptor-1 (IFNAR-1) was defective in IFN-beta treated U1.KR930 cells, but evident in U1.wt cells. In U1A-derived cells, the p85/p110 phosphoinositol 3-kinase isoform was associated with IFNAR-1 but not STAT3, and the association was ligand-independent. Further, IFN-beta treatment stimulated IFNAR-1-associated phosphoinositol kinase activity equally in either U1.wt or U1.KR930 cells. Our results indicate that catalytically active TYK2 is required for IFN-beta-mediated tyrosine phosphorylation of STAT3 and IFNAR-1 in intact cells.
Similar articles
-
Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.J Biol Chem. 1999 Jan 22;274(4):1891-7. doi: 10.1074/jbc.274.4.1891. J Biol Chem. 1999. PMID: 9890942
-
The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.J Interferon Cytokine Res. 2000 Nov;20(11):971-82. doi: 10.1089/10799900050198417. J Interferon Cytokine Res. 2000. PMID: 11096454
-
Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.Biochem J. 2004 Apr 1;379(Pt 1):199-208. doi: 10.1042/BJ20031495. Biochem J. 2004. PMID: 14690454 Free PMC article.
-
Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads.Front Immunol. 2021 Jan 20;11:615603. doi: 10.3389/fimmu.2020.615603. eCollection 2020. Front Immunol. 2021. PMID: 33552080 Free PMC article. Review.
-
Therapeutic Advantage of Tyk2 Inhibition for Treating Autoimmune and Chronic Inflammatory Diseases.Biol Pharm Bull. 2021;44(11):1585-1592. doi: 10.1248/bpb.b21-00609. Biol Pharm Bull. 2021. PMID: 34719635 Review.
Cited by
-
Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.J Inherit Metab Dis. 2013 Mar;36(2):235-46. doi: 10.1007/s10545-012-9522-x. Epub 2012 Sep 13. J Inherit Metab Dis. 2013. PMID: 22971960 Free PMC article.
-
Mechanism of shortened bones in mucopolysaccharidosis VII.Mol Genet Metab. 2009 Jul;97(3):202-11. doi: 10.1016/j.ymgme.2009.03.005. Epub 2009 Mar 25. Mol Genet Metab. 2009. PMID: 19375967 Free PMC article.
-
Interferon induction and function at the mucosal surface.Immunol Rev. 2013 Sep;255(1):25-39. doi: 10.1111/imr.12101. Immunol Rev. 2013. PMID: 23947345 Free PMC article. Review.
-
Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.Front Immunol. 2017 Jan 26;8:29. doi: 10.3389/fimmu.2017.00029. eCollection 2017. Front Immunol. 2017. PMID: 28184222 Free PMC article. Review.
-
STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling.J Virol. 2003 Jun;77(11):6385-93. doi: 10.1128/jvi.77.11.6385-6393.2003. J Virol. 2003. PMID: 12743296 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous